MERS
-
Preliminary Results Spell Good News for Inovio’s Ebola Vaccine
Plymouth Meeting’s Inovio Pharmaceuticals received good news from the preliminary results of its expanded stage phase I study of EBOV-001,…
MERS

Plymouth Meeting’s Inovio Pharmaceuticals received good news from the preliminary results of its expanded stage phase I study of EBOV-001,…